posted
too be expected after doubling since the 25th...I pulled some out yesterday cuz I thought this would be the case....No worries though this things a winner all the way!! Posts: 546 | From: Methuen, MA, USA | Registered: Aug 2003
| IP: Logged |
posted
everything is going down today...a very red market
we also had a few green days in a row, its only natural to have a red day today. Like I said in my previous post, don't follow this day to day, instead look ahead a week, a month or even a year...
quote:Originally posted by Nony: it is going daown any idea
quote:Originally posted by Moose: everything is going down today...a very red market
we also had a few green days in a row, its only natural to have a red day today. Like I said in my previous post, don't follow this day to day, instead look ahead a week, a month or even a year...
Posts: 50 | From: Malaysia | Registered: Dec 2003
| IP: Logged |
posted
Hey Folks, I was listening to CNBC on my XM earlier today and caught the tail end of a report on some sort of a medical confrence going on this week. They mentioned something about 5-6000 investors meeting with up and coming biotech companies. Each company was given 30 minute sessions with the investors to "sale" their company. CNBC was planning on interviewing some of the companies as the day went on. Just wondering if anyone has info on LBTT. Were they there? Can anyone add more to CNBC's report? Thanks-Chuck
Posts: 55 | Registered: Nov 2003
| IP: Logged |
posted
I have e-mailed investor relations for LBTT. I will forward any info...
quote:Originally posted by play on!: Hey Folks, I was listening to CNBC on my XM earlier today and caught the tail end of a report on some sort of a medical confrence going on this week. They mentioned something about 5-6000 investors meeting with up and coming biotech companies. Each company was given 30 minute sessions with the investors to "sale" their company. CNBC was planning on interviewing some of the companies as the day went on. Just wondering if anyone has info on LBTT. Were they there? Can anyone add more to CNBC's report? Thanks-Chuck
posted
They released PR's stating that they will be in two conferences...one that already has past, and another one in March.
So I would have to say that they did not attend this one, if they were going to attend I don't see why they did not release a PR.
-moose-
quote:Originally posted by play on!: Hey Folks, I was listening to CNBC on my XM earlier today and caught the tail end of a report on some sort of a medical confrence going on this week. They mentioned something about 5-6000 investors meeting with up and coming biotech companies. Each company was given 30 minute sessions with the investors to "sale" their company. CNBC was planning on interviewing some of the companies as the day went on. Just wondering if anyone has info on LBTT. Were they there? Can anyone add more to CNBC's report? Thanks-Chuck
posted
Well, That didn't take long! I'm still long and strong in this one. Here it is....
Dear Chuck:
Thanks for the info. It is slightly premature for the company to have an exhibit or to present at such a conference, esp. given that LBTT is a non-reporting pink sheet security. LBTT has no SEC filing or audited financials to show potential investors, and as such, it would not be productive to attend such an event.
posted
I just replied back asking this person to elaborate on the planned March conference. I'll pass it on when I get a response. These folks work late! I like that.....
Posts: 55 | Registered: Nov 2003
| IP: Logged |
quote:Originally posted by play on!: I just replied back asking this person to elaborate on the planned March conference. I'll pass it on when I get a response. These folks work late! I like that.....
posted
i wishe your limt$15 can come true but do u think that it can in the short run
quote:Originally posted by Moose: That sounds resonable....maybe a little high though ... we are ONLY saving lives you know, not building virtual keyboards!
[This message has been edited by Moose (edited January 13, 2004).]
[This message has been edited by Nony (edited January 13, 2004).]
Posts: 50 | From: Malaysia | Registered: Dec 2003
| IP: Logged |
Lifeline Biotechnologies, Inc. Signs North American Distribution Agreement with Inion Inc. For the Exclusive North American Distribution Of the Hexalon Bioabsorbable ACL/PLC Screw RENO, Nev., Jan 13, 2004 (BUSINESS WIRE) -- Jim Holmes, CEO of Lifeline (NQB:LBTT) today announced that Lifeline has signed an exclusive North American distribution agreement with Inion Inc. to distribute their Hexalon(TM) bioabsorbable ACL/PLC Screws and accessories to the orthopedic market.
The overall ACL/PCL fixation market for implants is estimated to be approximately $72 million in 2004. Interference screws are used in approximately 250,000 ACL/PCL repairs preformed in the US. This use makes up approximately 54% of the fixation market. Lifeline feels that with the design and strength advantages the Hexalon(TM) offers, their distribution network should be able to make an impact in the market, according to Jonathan Reeves, Lifeline Vice President of Operations.
Reeves commented further, "Surgeons want to eliminate the use of metal in joints. But until now, the widely recognized benefits of bioabsorbable materials have not been able to match the performance strength of titanium. The Inion Hexalon(TM) screw advantage is a combination of the resorbable biocompatibility with an operational performance equal to that of titanium. These unique characteristics are coupled with excellent visibility in the surgical field and an optimal self-tapping thread design for both bone to bone and hamstring graft fixations that will not damage grafts. These attributes place the Hexalon(TM) screw in a class of its own."
The marketing and sales strategies to introduce the Inion Hexalon(TM) product line are currently underway. Lifeline's network of distributors and sales representatives are excited about the potential of this product in the market. The addition of the Inion Product line fits perfectly into Lifeline's sales efforts in orthopedic surgery. Many of the distributors in Lifeline's distribution network have been responsible for the introduction of new products and surgical concepts, which have become standards of practice in orthopedic surgery today.
"We are pleased to announce this strategic distribution agreement with Lifeline Biotechnologies," said Kent Williams General Manager of Inion Inc. "We are confident in their ability to penetrate the U.S. and Canadian orthopedic sports medicine market with our Hexalon(TM) ACL bioabsorbable screw," added Kent Williams.
A joint product launch will take place at the American Academy of Orthopedic Surgeons in March 2004. However, Lifeline will begin its sales effort immediately as well as showing the product at the end of January at the Bob Metcalf Arthroscopic Surgery Conference and the American Association of Ambulatory Surgery Centers meeting at the beginning of March.
Dr. Reeves, Lifeline's founder and president, commented, "We are excited about this new product line because it allows us to introduce a product that has no peers because of Inion's leadership in developing superior polymers with superior surgical expertise. We are pleased that Inion has selected Lifeline to represent this product line considering Inion chose a company such as Stryker Sales Corporation to handle its Crano-Maxillofacial implants in North America."
Inion Ltd. was founded in Tampere, Finland in 1999 by a multidisciplinary, multinational team of international experts in biodegradable materials with related clinical applications. Today the company operates from a state-of-the-art production and research facility in Tampere, Finland and has US corporate headquarters in Oklahoma City, OK, employing 75 people. Other Inion products include biodegradable dental, orthopedic trauma and sports medicine devices marketed globally through distributors and direct sales personnel.
posted
Looks like they plan to attend two more conferences...this is good!
quote:From PR showing the product at the end of January at the Bob Metcalf Arthroscopic Surgery Conference and the American Association of Ambulatory Surgery Centers meeting at the beginning of March
posted
I bought in at .002. Have held my shares and will continue to hold through the ups and downs. I really think this is a good long term hold.
Posts: 172 | Registered: Oct 2003
| IP: Logged |
posted
I love this stock. It is my largest holding I sold my least expensive shares earlier but am trying to leave my .008 shares alone and let them grow for LT gains. I have been adding shares thru .038 in my account and also in my sisters and nieces accounts. If you are trying to accumulate it fluctuates down to .0295 if you are patient and lucky. If you don't have any shares I think it is great buy under .05 and if it is running on news you will not see a nickle except in the rear view mirror.
Posts: 1188 | From: Clinton, MA 01510 | Registered: Jan 2004
| IP: Logged |
THE MORE NEWS I GET ON THIS ONE THE MORE I RAISED THE LIMIT ORDER.
THE ONLY REASON I SEE LOWERING MY ORDER SELL PRICE IS DUE TO A UNFORSEEN REVERSE SPLIT WHICH IS PRETTY COMMON ONCE THEY START GAINING LARGE $$$ AMOUNTS. SO YES, I COULD LOWER MY LIMIT SELL BUT ONLY FOR THAT REASON.
I STARTED WITH MY LIMIT ORDER AT $2.00 AND RAISED IT TO $15 JUST RECENTLY.
quote:Originally posted by Nony: i wishe your limt$15 can come true but do u think that it can in the short run
[This message has been edited by Nony (edited January 13, 2004).]
posted
I think this will not go above 0.10+ for the next 2 month , but anyway let us hope for the best. Thanks
quote:Originally posted by U4TSAF2: WHAT IS YOUR SHORT TERM DEFINITION....
THE MORE NEWS I GET ON THIS ONE THE MORE I RAISED THE LIMIT ORDER.
THE ONLY REASON I SEE LOWERING MY ORDER SELL PRICE IS DUE TO A UNFORSEEN REVERSE SPLIT WHICH IS PRETTY COMMON ONCE THEY START GAINING LARGE $$$ AMOUNTS. SO YES, I COULD LOWER MY LIMIT SELL BUT ONLY FOR THAT REASON.
I STARTED WITH MY LIMIT ORDER AT $2.00 AND RAISED IT TO $15 JUST RECENTLY.
Posts: 50 | From: Malaysia | Registered: Dec 2003
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
